Insulin therapy in patients with cystic fibrosis in the pre-diabetes stage: a systematic review.

about

P2860

Q38656600-0DE5FDB2-CD0B-4320-BDD8-79C950675E93 Q47266208-222E9942-1C32-4E95-A99F-119A0D550734

P2860

Insulin therapy in patients with cystic fibrosis in the pre-diabetes stage: a systematic review.

Item

http://www.wikidata.org/entity/Q38781600

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Insulin therapy in patients wi ...... es stage: a systematic review.

@en

type

Item

label

Insulin therapy in patients wi ...... es stage: a systematic review.

@en

prefLabel

Insulin therapy in patients wi ...... es stage: a systematic review.

@en

P1476

Insulin therapy in patients wi ...... es stage: a systematic review.

@en

P2093

Aline Cristina Gonçalves

http://www.w3.org/2001/XMLSchema#string

Antonio Fernando Ribeiro

http://www.w3.org/2001/XMLSchema#string

Flávia Corrêa Christensen-Adad

http://www.w3.org/2001/XMLSchema#string

José Dirceu Ribeiro

http://www.w3.org/2001/XMLSchema#string

Mariana Zorrón Mei Hsia Pu

http://www.w3.org/2001/XMLSchema#string

Walter José Minicucci

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality

Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.

Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review.

Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society

Clinical improvement in cystic fibrosis with early insulin treatment

Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.

Glucose tolerance affects pubertal growth and final height of children with cystic fibrosis.

Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy.

Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia.

P304

367-373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1016/J.RPPED.2015.12.010

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2016-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26994743

http://www.w3.org/2001/XMLSchema#string

P921

P932

5178124

http://www.w3.org/2001/XMLSchema#string

Insulin therapy in patients with cystic fibrosis in the pre-diabetes stage: a systematic review.

about

P2860

P2860

Insulin therapy in patients with cystic fibrosis in the pre-diabetes stage: a systematic review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P433

P478

P5008

P577

P698

P921

P932